Glioma-associated oncogenes (GLIs) consist of three members: GLI1, GLI2, and GLI3, which are the downstream transcription factors involved in mediating the signaling pathway and leading to tumor progression [5, 6]. The gene discussed is GLI1; the disease is neoplasm.